SFI Frontiers for the Future, Project Grant Awarded
Prof. Silvia Giordani from the School of Chemical Sciences has been awarded the grant for her project, "Bio-Inspired Functionalisation of Nanoplatforms for Targeted Delivery of Therapeutics."
The research of the Giordani group is at the forefront of nanomedicine, focusing on the development of innovative drug delivery systems using carbon nano-onions (CNOs). This technology is poised to revolutionise cancer treatment by providing targeted, efficient, and low-dose therapies with minimal side effects. The precision and effectiveness of these new therapies could greatly improve patient outcomes, reduce treatment costs, and enhance the effectiveness of current medical interventions. Additionally, the advancements in nanotechnology being pursued hold promise for developing new diagnostic tools and therapeutic options, benefiting a broad range of health conditions.
Prof. Silvia Giordani expressed deep gratitude upon receiving the SFI Frontiers for the Future grant of €1,206,941.90, which she acknowledged as a significant recognition of her work and the potential impact of her research.
"I am deeply honoured to receive the SFI Frontiers for the Future grant."
Prof. Giordani also highlighted the enabling significance of this grant:
"I am grateful for the support from SFI and the confidence they have placed in our work. This grant will allow us to collaborate with leading experts, acquire cutting-edge technology, and accelerate our research."
Moreover, this research strongly aligns with the mission of the DCU Life Sciences Institute (LSI), a cornerstone of the university's research and teaching profile. By bringing together expertise across multiple disciplines, LSI plays a critical role in transforming challenges into impactful solutions, a vision shared by Prof. Giordani's work in nanomedicine.